US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 18, 2022 (5 years ago)

Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient

What was recalled

Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 007045 USA, NDC 0591-2132-01

Recalling firm
Teva Pharmaceuticals USA
NDC code
0591-2132-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0461-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all